CTOs on the Move

AstraZeneca

www.astrazeneca.com

 
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.astrazeneca.com
  • 1800 Concord Pike P.O. Box 15437
    Wilmington, DE USA 19850
  • Phone: 302.886.3000

Executives

Name Title Contact Details
Sean Connolly
Chief Technology Officer, Evinova Profile
Brooks Cucuel
Senior Director, Security and Business Resilience Profile

Similar Companies

HealthChem Contract Services

HealthChem Contract Services is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kyowa Hakko Kirin

Kyowa Kirin North America is a fully integrated specialty pharmaceutical company, where people work together to understand clinical needs and opportunities for innovation that can result in real advances for patients. Since 2018, the North American organization has received approval from the US Food and Drug Administration (FDA) to market 3 first-in-class medicines – achievements we share with the scientific, medical, and advocacy communities who contributed greatly to the success of these programs.

REDCON1

REDCON1 is a company that creates premium nutritional supplements for athletes of all levels, with the objective of bringing them to the highest state of readiness.

Tetraphase

Tetraphase Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel antibiotics to treat the serious and life-threatening multidrug-resistant infections that pose a major and growing global health threat. Tetraphase`s proprietary breakthrough chemistry technology enables the design of molecules that can overcome antibiotic resistance. Our drug platform has led to the creation of more than 3,000 broad- and selective-spectrum antibiotic drug candidates. Tetraphase common stock trades under the NASDAQ symbol `TTPH.` Tetraphase is well positioned to be a major player in the multidrug-resistant arena.

Americare Medical Supply

At Americare Medical Supply, we are committed to the excellence in terms of our Quality Products, Standards of Service, and Pricing. Client satisfaction is our number one priority and we take pride in providing quality products that make a difference i...